Skip to content

Malaria in Strasbourg University Hospital

Retrospective Clinical Study of Malaria in Strasbourg University

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03594084
Acronym
ACMUS
Enrollment
70
Registered
2018-07-20
Start date
2018-08-01
Completion date
2019-08-31
Last updated
2018-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malaria

Keywords

Malaria, Malaria imported cases, Recurrent malaria, Endemic malaria areas, Biological diagnosis, Hospital vs private laboratory diagnosis

Brief summary

The primary purpose is to describe the anamnestic, clinical, biological, and therapeutic characteristics of imported malaria in people originated from endemic areas. Indeed, clinicians have observed that people from such areas start malaria just after their arrival in France. Such observation needed to be confirmed. In addition, The investigators observed a variation in the laboratory diagnostic performance of malaria between hospital and private laboratories. Such observation also needed to be analyzed objectively

Interventions

None listed

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Days to No maximum

Inclusion criteria

- Patient over 18 years * Patients from birth to 18 years * Patient submitted to guardianship * Patient submitted to trusteeship * Diagnosis patients with malaria from 01/01/2017 to 01/01/2018 * Patient or legal representative agree to use medical data for this research

Exclusion criteria

* Lack of confirmation malaria diagnosis * Impossibility to inform patients * Patient who does not wish to participate in the study * Patient submitted to justice safeguarding

Design outcomes

Primary

MeasureTime frame
Study of clinical characteristics of imported malaria in people originated from endemic areas hospitalized at Strasbourg University Hospital from 2017 to 2018.The period from January 1st, 2017 to January 1st, 2018 will be examined

Countries

France

Contacts

Primary ContactXavier ARGEMI, MD
xavier.argemi@chru-strasbourg.fr33 3 69 55 11 87
Backup ContactAnne DINDOYAL, MD
anne.dindoyal@chru-strasbourg.fr33 3 69 55 11 87

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026